Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma：a Randomized Controlled Study

NCT04056962 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT04056962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04056962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma：a Randomized Controlled Study
Lead sponsor
West China Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
September 1, 2019
Completion date
October 28, 2024
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tacrolimus, kaposiform hemangioendothelioma, tufted angioma